Authors


Andrew Griffiths

Latest:

Revolutionizing Clinical Trials Through Real-Time Data Capture and Analytics

This article discusses real-time data capture and analytics in clinical trials.


James P Angus

Latest:

Revolutionizing Clinical Trials Through Real-Time Data Capture and Analytics

This article discusses real-time data capture and analytics in clinical trials.


Andy N Brown

Latest:

Revolutionizing Clinical Trials Through Real-Time Data Capture and Analytics

This article discusses real-time data capture and analytics in clinical trials.





Lee Horner

Latest:

Value of Virtual Care Technology in Clinical Trials

Virtual care technology is emerging as a valuable tool for clinical trials, helping to improve recruiting and strengthen retention while optimizing resources for the overall study.



Julie Schulman

Latest:

Models of Engagement: Patients as Partners in Clinical Research

Exploring three distinct patient partnership models to help researchers assess which methods of engagement could work best for their clinical programs.


Kirk Jernigan

Latest:

Models of Engagement: Patients as Partners in Clinical Research

Exploring three distinct patient partnership models to help researchers assess which methods of engagement could work best for their clinical programs.


Patty McAdams

Latest:

Models of Engagement: Patients as Partners in Clinical Research

Exploring three distinct patient partnership models to help researchers assess which methods of engagement could work best for their clinical programs.


Lindsay Singler

Latest:

Models of Engagement: Patients as Partners in Clinical Research

Exploring three distinct patient partnership models to help researchers assess which methods of engagement could work best for their clinical programs.


Kathleen Sanzo

Latest:

FDA Issues Final Rule on Data Acceptance from Clinical Investigations for Medical Devices

The FDA published a final rule on FDA’s standards for accepting data from clinical investigations for medical devices on February 21.


Michele L. Buenafe

Latest:

What Pharma Companies Need to Know About FDA's New Draft IVD Guidance

The FDA's new draft IVD Guidelines will need to be factored into how pharma clinical trial sponsors use IVDs in a clinical trial, study design, timeline for protocol development, IND submission, and study initiation.


Nimita Limaye, PhD

Latest:

A Roadmap for Implementing RBM and Quality Management

The importance of applying change management techniques throughout the preparation, planning, and execution of RBM and RBQM approaches.


Awani Saraogi

Latest:

How Social Media is Transforming Pharma and Healthcare

Outlining the growing attention and pursuits around social media in adverse event reporting and advancing patient-centric initiatives in clinical trials.   


Robert Collins

Latest:

Making Real-World Evidence Real

An expert view on how sponsors can formalize the use of real-world data and generation of real-world evidence to drive critical insights.


Annick Anderson

Latest:

Trends in Global Public and Patient Perceptions of Clinical Research

To inform our understanding of public and patient trust and confidence, this article provides a high-level summary of the results of two studies monitoring trends in international public and patient attitudes and perceptions.


Nova Getz

Latest:

Trends in Global Public and Patient Perceptions of Clinical Research

To inform our understanding of public and patient trust and confidence, this article provides a high-level summary of the results of two studies monitoring trends in international public and patient attitudes and perceptions.


Jasmine Benger

Latest:

Sharing Stories of Clinical Trial Participation from Start to Finish

How mapping patients’ health journeys can drive a deeper understanding of their experiences and motivations.


Joan Chambers

Latest:

Leveraging Technology to Bridge Clinical Trial Processes and Real-World Health Care

Building upon the usage of technology in health care delivery, integrating technology into clinical research as a care option will be a game changer in achieving greater participation in clinical research and decreasing the overall time for trial completion.


Naomi Fujimoto

Latest:

Leveraging Technology to Bridge Clinical Trial Processes and Real-World Health Care

Building upon the usage of technology in health care delivery, integrating technology into clinical research as a care option will be a game changer in achieving greater participation in clinical research and decreasing the overall time for trial completion.



Joshua C. Rubin

Latest:

Applying Learning Health Systems to Advance Clinical Research and Health Care

The use of Learning Health Systems in order to advance clinical research.


Phoebe Mounts

Latest:

FDA Issues Final Rule on Data Acceptance from Clinical Investigations for Medical Devices

The FDA published a final rule on FDA’s standards for accepting data from clinical investigations for medical devices on February 21.


Suzanne Bassett

Latest:

FDA Issues Final Rule on Data Acceptance from Clinical Investigations for Medical Devices

The FDA published a final rule on FDA’s standards for accepting data from clinical investigations for medical devices on February 21.


Richard Hamermesh, DBA

Latest:

Master Protocols in Oncology: A Review of the Landscape

With technology’s increasing ability to gather and analyze previously unmanageable data sets, and medicine’s forays into genomics and targeted therapies, the time of the master protocol may be at hand.


Kathy Giusti, MBA

Latest:

Master Protocols in Oncology: A Review of the Landscape

With technology’s increasing ability to gather and analyze previously unmanageable data sets, and medicine’s forays into genomics and targeted therapies, the time of the master protocol may be at hand.


Bradley Smith, PhD

Latest:

Master Protocols in Oncology: A Review of the Landscape

With technology’s increasing ability to gather and analyze previously unmanageable data sets, and medicine’s forays into genomics and targeted therapies, the time of the master protocol may be at hand.


Dixie-Lee W. Esseltine, MD

Latest:

Master Protocols in Oncology: A Review of the Landscape

With technology’s increasing ability to gather and analyze previously unmanageable data sets, and medicine’s forays into genomics and targeted therapies, the time of the master protocol may be at hand.

© 2024 MJH Life Sciences

All rights reserved.